-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: Features of the ELISpot Platform
Author:
InnoModels Biotechnology
Release time:
2024-02-02
The InnoModels Biotechnology ELISpot platform provides researchers with a highly sensitive and specific method to accurately and rapidly analyze cell-secreted proteins, providing powerful support for research in immunology, oncology and other fields.
Technical features of ELISpot platform
1. High sensitivity and specificity:
The ELISpot platform tracks individual secreting cells by optical technology, realizing highly sensitive detection of tiny protein concentrations. Its highly specific detection method ensures accurate analysis of target molecules, providing researchers with a unique research advantage.
2. Single-cell analysis:
The ELISpot platform not only analyzes cell secretion at the population level, but also enables the analysis of individual cells. This feature enables researchers to gain a deeper understanding of the secretion heterogeneity among cell subpopulations, providing strong support for individualized treatment and research.
3. Multi-parameter analysis:
The ELISpot platform supports the simultaneous detection of multiple molecules secretion, through multi-parameter analysis, researchers can fully understand the expression level of different proteins, revealing the complexity of the cellular secretion network, which provides a powerful tool for in-depth study of the immune response.

4. Flexible experimental design:
ELISpot platform has flexible experimental design for different types of cells and secreted molecules. Researchers can choose different reagent kits according to their research needs and realize personalized experimental design to better meet their research needs.
5. Automatic data analysis and interpretation:
The ELISpot platform is equipped with advanced automated data analysis software, which enables researchers to quickly access, interpret and share experimental data. This feature reduces the difficulty of experimental operation, improves experimental efficiency, and allows researchers to focus on in-depth analysis of data.
Scientific Applications and Future Prospects
1. Immune monitoring and vaccine development:
The ELISpot platform is widely used in immunosurveillance and vaccine development, and can accurately assess cell-mediated immune responses, providing powerful support for vaccine efficacy evaluation and immunotherapy monitoring.
2. Tumor immunology research:
In tumor immunity research, ELISpot platform can reveal the secretion characteristics of immune cells in the tumor microenvironment, providing important information for the design and optimization of tumor immunotherapy.
3. autoimmune disease research:
The application of ELISpot platform in autoimmune disease research is expected to help researchers gain a deeper understanding of the mechanism of aberrant immune response, and provide new ideas for the development of therapies for related diseases.
Conclusion
With its excellent technical features, the ELISpot platform of InnoModels Biotechnology will surely become a leading tool in the field of cell secretion research. With its wide application in different research fields, the ELISpot platform will continue to promote the further development of scientific research and contribute to unlocking the mysteries of cell secretion potential.
Previous Page
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd